Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4

被引:0
|
作者
Ohata, Yasuhisa [1 ]
Mori, Jun [2 ]
Fujisawa, Yasuko [3 ]
Sato, Yukihito [4 ]
Rohrich, Sebastian [5 ]
Rasmussen, Michael Hojby [6 ]
Bang, Rikke Beck [7 ]
Horikawa, Reiko [8 ]
机构
[1] Osaka Univ, Dept Pediat, Grad Sch Med, Suita, Osaka, Japan
[2] Osaka City Gen Hosp, Div Pediat Endocrinol & Metab, Childrens Med Ctr, Osaka, Japan
[3] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4, Japan
[4] Novo Nordisk Pharma Ltd, Tokyo, Japan
[5] Novo Nordisk AS, Zurich, Switzerland
[6] Novo Nordisk AS, Clin Drug Dev, Soborg, Denmark
[7] Novo Nordisk AS, Aalborg, Denmark
[8] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo, Japan
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FC11.5
引用
收藏
页码:65 / 66
页数:2
相关论文
共 50 条
  • [1] GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4
    Miller, Bradley
    Blair, Joanne
    Rasmussen, Michael Hojby
    Maniatis, Aristides
    Mori, Jun
    Boettcher, Volker
    Bang, Rikke
    Polak, Michel
    Horikawa, Reiko
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 63 - 64
  • [2] Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH
    Miller, Bradley S.
    Blair, Joanne C.
    Rasmussen, Michael Hojby
    Maniatis, Aristides
    Mori, Jun
    Boettcher, Volker
    Kim, Ho-Seong
    Bang, Rikke Beck
    Polak, Michel
    Horikawa, Reiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : E1700 - E1709
  • [3] Effective GH Replacement With Once-weekly Somapacitan vs Daily GH in Children with GHD: 3-year Results From REAL 3
    Savendahl, Lars
    Battelino, Tadej
    Rasmussen, Michael Hojby
    Brod, Meryl
    Saenger, Paul
    Horikawa, Reiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (05): : 1357 - 1367
  • [4] Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial
    Savendahl, Lars
    Battelino, Tadej
    Brod, Meryl
    Rasmussen, Michael Hojby
    Horikawa, Reiko
    Juul, Rasmus Vestergaard
    Saenger, Paul
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : E1847 - E1861
  • [5] Effective growth hormone replacement with once-weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial
    Mori, Jun
    Ohata, Yasuhisa
    Fujisawa, Yasuko
    Sato, Yukihito
    Rohrich, Sebastian
    Rasmussen, Michael H.
    Bang, Rikke Beck
    Horikawa, Reiko
    CLINICAL ENDOCRINOLOGY, 2024, 100 (04) : 389 - 398
  • [6] Once-Weekly Somapacitan versus Daily GH in Children with GH Deficiency: The Randomized Phase 3 REAL 4 Trial
    Miller, Bradley
    Blair, Joanne
    Hojby, Michael
    Boettcher, Volker
    Kildemoes, Rasmus Juul
    Maniatis, Aristides
    Bang, Rikke Beck
    Mori, Jun
    Polak, Michel
    Stagi, Stefano
    Horikawa, Reiko
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 277 - 277
  • [7] Weekly Somapacitan is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial
    Miller, Bradley S.
    Blair, Joanne C.
    Rasmussen, Michael Hojby
    Maniatis, Aristides
    Kildemoes, Rasmus Juul
    Mori, Jun
    Polak, Michel
    Bang, Rikke Beck
    Boettcher, Volker
    Stagi, Stefano
    Horikawa, Reiko
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (12): : 3378 - 3388
  • [8] Effective GH Replacement With Somapacitan in Children With GHD: REAL4 2-year Results and After Switch From Daily GH (05 Jul, 10.1210/clinem/dgad394, 2023)
    不详
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : E1688 - E1688
  • [9] Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial
    Johannsson, Gudmundur
    Gordon, Murray B.
    Rasmussen, Michael Hojby
    Hakonsson, Ida Holme
    Karges, Wolfram
    Svaerke, Claus
    Tahara, Shigeyuki
    Takano, Koji
    Biller, Beverly M. K.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (04): : E1358 - E1376
  • [10] Pharmacodynamic Endpoints After Once-Weekly Somapacitan in Children With GHD: 3-year results from REAL4 phase 3 study
    Miller, Bradley S.
    Blair, Joanne C.
    Rasmussen, Michael Hojby
    Maniatis, Aristides
    Mori, Jun
    Boettcher, Volker
    Kim, Ho-Seong
    Polak, Michel
    Horikawa, Reiko
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 87 - 87